Navigation Links
Statins Reduced Death Risk From Pneumonia
Date:10/28/2008

One-third lower mortality for hospitalized patients, study found

TUESDAY, Oct. 28 (HealthDay News) -- The death rate among people hospitalized for pneumonia was one-third lower for those taking statins than for those not taking the cholesterol-lowering drugs, a Danish study found.

While the findings are preliminary and offer hope, more research is needed before doctors can prescribe statins as infection fighters, experts said.

"I think we need to interpret these findings with caution," said Dr. Reimar W. Thomsen, professor of clinical epidemiology at Aarhus University, and lead author of a report in Oct. 27 issue of the Archives of Internal Medicine.

But statins are known to have an anti-inflammatory effect, Thomsen said, and "we are just beginning to understand that systemic infections such as pneumonia cause inflammation that may trigger a lot of adverse reactions in human bodies."

It's possible that other factors, such as the "healthy-user effect," meaning that people who take statins are in better shape and take better care of themselves, might explain the results of the study, Thomsen added.

"However, we aimed to control for most of the confounding factors in the analyses," he said. "I do not find it likely that confounding explains the whole statin effect."

Other drugs for coronary conditions, such as beta-blockers and aspirin, did not have any effect on pneumonia mortality in the study, Thomsen noted.

Thomsen and his colleagues reviewed data on 29,900 adults hospitalized with pneumonia between 1997 and 2004. Of these, just 1,371 were taking statins at the time. The 30-day death rate for the statin group was 10.3 percent, compared to 15.7 percent for those not taking statins. The 90-day death rate was 16.8 percent for the statin group and 22.4 percent for those not taking the drugs.

"Healthy user plus biological effects cause this finding," Thomsen said. "The relative impact of both can only be determined by randomized trials. Such trials need to enroll several thousand people with pneumonia, meaning high costs, and would need to include typical pneumonia patients, which are elderly, frail patients with several morbidities."

Until such studies are done, Thomsen said, "I think it is too early to make recommendations about statin therapy for severe infection or treatment. We have learned from the lesson of hormone-replacement therapy and antioxidants, when some doctors and drug companies prematurely recommended drugs on the basis of positive observational studies, that therapeutic recommendations should not be based on animal studies, plausible biological mechanisms, and findings from observational studies."

One controlled trial to see whether statins help treat infections is starting at the University of Chicago.

"We are looking specifically at patients with severe infections, sepsis," said Dr. Jeffrey Jacobson, assistant professor of medicine and leader of the trial. "They will be randomized to simvastatin [Zocor] or placebo for four days."

Jacobson cited the anti-inflammatory properties of statins noted by Thomsen. "My work is specifically about the ability to protect the vasculature [blood vessels]," he said. "If you can prevent vascular leakage, you can reduce morbidity and subsequent complications and mortality."

Several previous observational studies that indicated a protective effect of statins against infection provide "a legitimate rationale for exploring these drugs," Jacobson said. "We do know that clinical trials are long overdue."

The goal is to complete the study within a year, "but it might be closer to two years," Jacobson said.

While he agreed that the current evidence does not support use of statins in the treatment of infections, "what is really promising about them is that they are readily available, relatively safe and affordable, and can be used immediately," he said.

More information

Learn more about statins and other drugs that lower cholesterol from the American Heart Association.



SOURCES: Reimar W. Thomsen, M.D., Ph.D, professor of clinical epidemiology, Aarhus University, Denmark; Jeffrey Jacobson, M.D., assistant professor of medicine, University of Chicago; Oct. 27, 2008, Archives of Internal Medicine


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Statins Lower Risk of Clots in Cancer Patients
2. Statins show promise for blood clot prevention
3. Statins Show Promise for Blood Clot Prevention
4. Statins Help Obese People After Bypass Surgery
5. Research Shows Why Statins Dont Work for Everyone
6. Statins May Help Older Women Control Irregular Heartbeat
7. When statins arent enough: New trial drug points to better management of coronary heart disease
8. iGuard.org Presents New Data on Statins at FDA Workshop Demonstrating How Patient-Reported Information Can Enhance Drug Safety Knowledge
9. Women are treated less frequently than men with statins, aspirin and beta-blockers
10. Cholesterol-Lowering Statins Tied to Tendon Woes
11. Tendon complications, though rare, linked to statins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... MetLoop CEO ... new 2.0 version at the International Roofing Expo in Orlando, Florida on February ... world's most advanced weather technology in the hands of consumers, roofing contractors, manufacturers ...
(Date:2/10/2016)... ... 2016 , ... The Wickman Agency in Garland, TX has ... community. Pledging to select a new beneficiary every 60 days, the agency will ... is to bring community awareness to important local causes by forming campaigns which ...
(Date:2/10/2016)... Tucson, AZ (PRWEB) , ... February 10, 2016 , ... ... prompted the Aging Life Care Association™ (ALCA) to conduct a survey that takes a ... aging experts released today illustrates the prevalence and causes of TBI among the aging ...
(Date:2/10/2016)... ... 10, 2016 , ... Armune BioScience signed a definitive agreement with ... service centers across the country. Launched in April of 2015, Apifiny is the only ... cancer. Apifiny order volume exceeded 3,000 tests in 2015. Primary care physicians and urologists ...
(Date:2/10/2016)... ... February 10, 2016 , ... The Club ... awarded the prestigious Distinguished Emerald Club of the World award, as determined by ... one of the most respected trade publications serving private clubs. , “We’d like ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , February 10, 2016 ... "Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market ... Technologies, Participants, and Environment" research report indicates that ... over $149 billion by 2020 growing at a ... of companion diagnostics and targeted therapeutics and is ...
(Date:2/9/2016)... CITY, Calif. , Feb. 9, 2016 /PRNewswire/ - ... device company that is providing innovative evidence-based solutions for ... will release financial results for the fourth quarter and ... February 29, 2016. Company management will host a conference ... Eastern Time) on Monday, February 29, 2016. ...
(Date:2/9/2016)... BILLERICA, Mass. , Feb. 9, 2016  Insulet Corporation ... in tubeless insulin pump technology with its OmniPod ... David A. Lemoine has been appointed to Insulet,s ... comprised of nine directors, eight of whom are independent. ... over 40 years of audit and finance experience and a ...
Breaking Medicine Technology: